Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

6 Stocks To Watch: AMRN, ARWR, CLVS, EOLS, OSTK, ROKU

Published 02/27/2019, 11:53 PM
Updated 07/09/2023, 06:31 AM

It was a mixed session on Wall Street on Wednesday, with a big drop in the morning, and a comeback in the afternoon. A lot of stocks we follow participated. There’s a lot of new ones to show you as well.

Amarin Corporation plc (AMRN)

NASDAQ:AMRN had a good day on Wednesday, up 1.17, or 5.85%, to 21.18, on 15.5 million shares, and closed at the upper end of the range. That’s good volume for this stock and it might be on its way. The breakout at the congestion zone, the 2-3 days of consolidation, and Wednesday’s pop, I think, may have it headed to retest the high at 23.14 short-term, and then 27.

Arrowhead Pharmaceuticals, Inc. (ARWR)

NASDAQ:ARWR has a beautiful base and breakout, I put a swing on it at that point, and it ran from almost 15 to 20 on Wednesday, popping 55 cents, or 2.87%, to 19.70 with a high to 19.80, on 1.6 million shares. The spike high in October was 20.31. It may test that area on Thursday. It’s a little extended, but with the rising flag and current momentum, it may very well test the September high over 22.

Clovis Oncology, Inc. (CLVS)

NASDAQ:CLVS had a beautiful pop on Wednesday, jumping 3.43, or 13%, to 29.48, on 4.5 million shares. That’s the biggest volume in a couple months on a breakout day. But I’ll take it! Right now the angle of ascent appears to be headed to the mid-to-high 30’s.

Evolus, Inc. (EOLS)

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

EOLS one of our swing trades, went from the 14.50 level to nearly 29, nearly doubling, and formed a nice 2-3 wave corrective pullback. It broke out and advanced 1.93, or 7.65%, to 27.18, on 1.45 million shares. It may be testing as early as Thursday, the 28-28 1/2 zone, and if it gets through that then the 33-33 1/4 range. It might see 34. It has tremendous momentum.

Overstock.com, Inc. (OSTK)

OSTK snapped back beautifully on Wednesday after a week of declining. It climbed 2.30, or 12.94%, to 20.08, on 6.3 million shares. That’s big volume for this stock. It closed at the upper end of the range. I still need it to take out the 23 range. If it does that, you could see 26-27.

Roku, Inc. (ROKU)

ROKU has been a phenomenal swing since we gave it to you in January around the 38-39 zone, nearly doubling. On Thursday it was up 2.29, or 3.52%, to 67.37, on 9.7 million shares. It’s testing resistance up in the 38-9 area and it stalled here. It looks to me like it wants to run through it and up to 78-79.

Stocks On The Long Side

ACADIA Pharmaceuticals Inc. (ACAD), Amarin Corporation plc (AMRN), Arrowhead Pharmaceuticals, Inc. (ARWR), CareDx, Inc (CDNA), Chesapeake Energy Corporation (NYSE:CHK), Clovis Oncology, Inc. (CLVS), California Resources Corporation (CRC), Enphase Energy, Inc. (ENPH), Evolus, Inc. (EOLS), iCAD, Inc. (ICAD), Invitae Corporation (NVTA), Overstock.com, Inc. (OSTK), Qutoutiao Inc. (QTT), Roku, Inc. (ROKU), Sea Limited (SE), StoneCo Ltd. (STNE), Supernus Pharmaceuticals, Inc. (SUPN), Tellurian Inc. (TELL), Telaria, Inc. (TLRA), Tandem Diabetes Care, Inc. (TNDM), Veracyte, Inc. (VCYT), Voyager Therapeutics, Inc. (VYGR), Xenon Pharmaceuticals Inc. (XENE), Xunlei Limited (XNET), Zogenix, Inc. (ZGNX), Zosano Pharma Corporation (ZSAN).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Watch Video here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.